Latest Regulatory News


Regulatory Flexibility for Veterinary Medicines during COVID-19 Pandemic

The European Commission, EMA and the Coordination Group for Mutual Recognition and Decentralised Procedure (Veterinary) have issued guidance on adaptations to the regulatory framework to companies that develop, manufacture and distribute veterinary medicines in order to address some of the constraints posed by the COVID-19 pandemic.

According to the jointly developed question-and-answer (Q&A) document, regulatory rules for veterinary medicines should be applied with greater flexibility in the context of COVID-19 when necessary to mitigate the risk of supply disruptions caused by the pandemic. The guidance aims to ensure that high-quality, safe and effective veterinary medicines that are essential for protecting public and animal health continue to be available during the public health crisis.

The Q&A document sets out areas where regulatory flexibility is possible to address some of the constraints marketing authorisation holders in the veterinary sector may be faced with in the context of the pandemic. These measures cover different areas of regulation, including:

  • marketing authorisation procedures;
  • safety monitoring; and
  • inspections of manufacturing facilities and good manufacturing practice (GMP) for veterinary medicines.

The Q&A document was also endorsed by the EU Executive Steering Group on Shortages of Medicines Caused by Major Events, which provides strategic leadership for urgent and coordinated action on possible shortages within the EU during this pandemic.

The Q&A document will be continuously updated. Veterinary stakeholders are advised to visit this page for regulatory information on the impact of the COVID-19 pandemic on veterinary medicines.

 

Latest Regulatory News

Nov-2020

Chemicals and REACH > News

Draft Guidance for Chemical Registration in China

In August 2020, the Chinese Ministry of Ecology and Environment (MEE) released the anticipated draft Guidance for Environmental Management Registration of New Chemical Substances for...

Read More

Oct-2020

News > Vet Medicine

Antimicrobial Resistance and Environmental Impact of Parasiticides

Two expert groups (DEG and ERAWP) from the Committee for Medicinal Products for Veterinary Use (CVMP) are, as part of the Work Plan 2020, focussing...

Read More

Contact

LKC Switzerland Ltd
Hauptstrasse 10
P.O. Box 167
4414 Füllinsdorf
Switzerland

Phone: +41 (0) 61 906 8500
Fax: +41 (0) 61 906 8509
LKC@lkc-ltd.com

Information

Registration Number: CHE-113.597.134

Upcoming Events

2007-2020 © Copyright LKC Switzerland Ltd

Sign Up for Newsletter

x